Both in Medical Labs
Sera Prognostics vs Castle Biosciences
Over the past year SERA returned −45.9% and CSTL returned +51.9%; their daily moves had a correlation of 0.10.
SERA −45.9% CSTL +51.9%Growth of $1, one year, split-adjusted
| Metric | SERA | CSTL |
|---|---|---|
| Price | $2.03 | $36.68 |
| Market cap | $80.1M | $1.12B |
| Today | −0.98% | +6.29% |
| 1 month | +1.0% | +5.2% |
| 6 months | +2.0% | +51.3% |
| Year to date | −31.2% | −5.7% |
| 1 year | −45.7% | +53.1% |
| Revenue growth (YoY) | +76.5% | +20.1% |
| Gross margin | −66.7% | 77.1% |
| Net margin | −30463.3% | −2.0% |
| P/E (TTM) | — | — |
| Price / sales | 1,144.0× | 3.1× |
| Net cash | $46.4M | $256.5M |
| Dividend yield | — | — |
| Volatility (60d) | 34.0% | 49.9% |
| Short % of float | 0.7% | 7.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).